Navigation Links
Research could lead to new non-antibiotic drugs to counter hospital infections
Date:4/8/2009

Lack of an adequate amount of the mineral phosphate can turn a common bacterium into a killer, according to research to be published in the April 14, 2009, issue of the Proceedings of the National Academies of Science. The findings could lead to new drugs that would disarm the increasingly antibiotic-resistant pathogen rather than attempting to kill it.

Pseudomonas aeruginosa is one of the most serious hospital-acquired pathogens. A common cause of lung infections, it is also found in the intestinal tract of 20 percent of all Americans and 50 percent of hospitalized patients in the United States.

It is one of the hundreds of bacteria that colonize the human intestinal tract, usually causing no apparent harm. It might even be beneficial to its host. Once the host is weakened by an illness, surgical procedure or immunosuppressive drugs, however, P. aeruginosa can cause infection, inflammation, sepsis and death.

Why P. aeruginosa can suddenly turn on its host has eluded researchersuntil now. Scientists have long known that after an operation or organ surgery, levels of inorganic phosphate fall. The authors of the PNAS paper, led by scientists at the University of Chicago, hypothesized that phosphate depletion in the stressed intestinal tract signals P. aeruginosa to become lethal.

To test this theory, they let worms (Caenorhabditis elegans) feed on "lawns" of P. aeruginosa and Escherichia coli grown in both low-phosphate and high-phosphate media. Only the worms that ate P. aeruginosa with low levels of phosphate died. The researchers dubbed the phenomenon "Red Death" since unexpected large red spots appeared on the worms before they died.

"These findings provide novel insight into the mechanisms by which P. aeruginosa is able to shift from indolent colonizer to a lethal pathogen when present in the intestinal tract of a stressed host," said Alexander Zabo
'/>"/>

Contact: Greg Borzo
greg.borzo@uchospitals.edu
773-795-0892
University of Chicago Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...BER 25, 2009 Soil is the linchpin of the environm...meet. Despite that, many students see soil as "jus... Soil science educators are challenged with the ta...e critical importance of soil in the environment. ...arth science teachers at University of Nebraska-Li...
(Date:11/24/2009)...ears it has been prescribed by traditional healers...ches and stomach pain to fever and flu. , Now for...ty have been able to scientifically prove the pain...se known as Brazilian mint. , Testing this ancien...earcher Graciela Rocha was able to show that when ...
(Date:11/24/2009)...eakened and flabby arteries from collapsing have b...stents are no longer needed -- once the arteries a...ly, doctors had no choice but to leave them in pla...ity,s Department of Biomedical Engineering has dev...rries drugs where they,re needed, then dissolves. ...
Breaking Biology News(10 mins):It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 1Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 2Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 3Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 4Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 1Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 2Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 3Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 4Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 5Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 6Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 7Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 8MedCath Names Art Parker Executive Vice President and Chief Financial Officer 58084 1MedCath Names Art Parker Executive Vice President and Chief Financial Officer 58084 2
...r eye diseases and leading causes of blindnessage-...thycan be reversed or even prevented by drugs that...esearchers at the University of Utah School of Med...d in a new study. , Damage from both diseases was...o4, was activated in mice models that simulate age...
...oneers in small RNA research--Victor Ambros, Gary ...recent discoveries at a special half-day symposium...0 p.m., Wednesday, April 16, in the Gore Recital H...nt will be held in their honor, as the 2008 winner...dal in Life Science. , UD,s symposium is part of ...
...nderstand how nitrogen accumulates in large rivers...Walter Dodds looked at small streams flowing close...sas State University, didn,t have to look any fart... Creek at K-State was one of nine small waterways ... nitrogen is removed from streams. With a grant fr...
Other Biology News:Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 3Pioneers in small RNA research to present at UD symposium, April 16 2Pioneers in small RNA research to present at UD symposium, April 16 3Research team finds that microorganisms filter nitrogen from small streams 2
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ -...d & Drug Administration (SFDA) has approved th...ts oral insulin project,(Nodlin), an innovative in...oval allows Biolaxy to initiate its first phase I ...characteristic of high blood glucose and poor,meta...
(Date:11/24/2009)... The FBI recently approved the Pr...es participating in or generating DNA records for ... Madison, WI USA (PRWEB) -- The FBI recentl...m for use by laboratories participating in, or ge...ystem (NDIS). NDIS currently contains more than se...
(Date:11/24/2009)..., TSX VENTURE: HTL , TORONTO, Nov. 24 /PRN...HTL), formerly Calotto Capital Inc., a leading pro...r the stem cell research and fertility clinic mark...lts for the third quarter ended September 30, 2009...$1.46 million compared with $1.43 million in Q3 20...
(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-First...A ) announced today that the company is schedule...th Care Conference on December 1, 2009 at 11:30 a....w York Palace Hotel in New York City. Jack Lief, A...cheduled to provide an overview of the company, in...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...ANCOUVER and SAN DIEGO, Jan. 31 /PRNewswire-FirstC...ical-stage developer of drugs for infectious,disea...py arm to its,currently enrolling Phase II viral k...nt-naive patients. The protocol amendment to this ... Review Board (IRB) approvals. The,purpose of this...
...oundation Continues Research Initiatives in Search... for Paralysis, SHORT HILLS, N.J., Jan. 31 The...ch is dedicated to curing spinal cord injury by,fu...y of life for people,living with paralysis through... it has awarded $1,996,745 million to 16 laborator...
...ILLBROOK, N.Y., Jan. 31 Mr. Donald Fresne, Chairm...he company has recently,obtained from Harvard Univ...ts that cover certain technologies related to canc...chnologies, which were developed jointly,by scient...and the,Department of Biological Chemistry and Mol...
Other Biology Technology:MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 2MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 3MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 4MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 5MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 6Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 2Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 3
...ptimised for SYBR Green I assays and contain all t...R, with the exception of template and primers. The... active SYBR Green I dye and Thermo-Start DNA Poly...hat enables detection of low copy number targets.,...
... all-in-one rotator/rocker with a multi-action pla... rotating, rocking/shaking, rotating/rocking, rol...mbination of all these actions. The precision-eng... Genie consists of a two-sided, stainless steel pl...
...ion Kit, Plasmid is designed for use with high-yie...No. 3 186 148, 3 186 156, 3 335 461). This kit pro... N-terminal AviTag peptide sequence. The expressed... E. coli biotin protein ligase (BirA, E.C. 6.3.4.1...
... RFC1 Immunogen Recombinant protein correspondin... expressed in E. coli. Reactivity / Specificity ... tested in other species. This antibody recognizes... Replication factor C is a multisubunit, DNA polym...
Biology Products: